These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15991762)

  • 1. Integration of a clinical community pharmacist position: emphasis on workflow design.
    Pai AK
    J Am Pharm Assoc (2003); 2005; 45(3):400-3. PubMed ID: 15991762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telepharmacy services in an urban community health clinic system.
    Lam AY; Rose D
    J Am Pharm Assoc (2003); 2009; 49(5):652-9. PubMed ID: 19748874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of a health information exchange into community pharmacy workflow.
    Hohmeier KC; Spivey CA; Boldin S; Moore TB; Chisholm-Burns M
    J Am Pharm Assoc (2003); 2017; 57(5):608-615. PubMed ID: 28733155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of community pharmacy tech-check-tech as a strategy for practice advancement.
    Fleagle Miller R; Cesarz J; Rough S
    J Am Pharm Assoc (2003); 2018; 58(6):652-658. PubMed ID: 30170967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of workflow redesign in community pharmacy.
    Angelo LB; Ferreri SP
    J Am Pharm Assoc (2003); 2005; 45(2):145-50. PubMed ID: 15868756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of community pharmacy automation on workflow, workload, and patient interaction.
    Angelo LB; Christensen DB; Ferreri SP
    J Am Pharm Assoc (2003); 2005; 45(2):138-44. PubMed ID: 15868755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
    Isho NY; Kachlic MD; Marcelo JC; Martin MT
    J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Iowa new practice model: Advancing technician roles to increase pharmacists' time to provide patient care services.
    Andreski M; Myers M; Gainer K; Pudlo A
    J Am Pharm Assoc (2003); 2018; 58(3):268-274.e1. PubMed ID: 29606624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a vaccine screening program at an independent community pharmacy.
    Rhodes LA; Branham AR; Dalton EE; Moose JS; Marciniak MW
    J Am Pharm Assoc (2003); 2017; 57(2):222-228. PubMed ID: 27964886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient counseling provided in community pharmacies: effects of state regulation, pharmacist age, and busyness.
    Svarstad BL; Bultman DC; Mount JK
    J Am Pharm Assoc (2003); 2004; 44(1):22-9. PubMed ID: 14965149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric asthma medication therapy management through community pharmacy and primary care collaboration.
    Bradley CL; Luder HR; Beck AF; Bowen R; Heaton PC; Kahn RS; Mansour M; Obszarski S; Frede SM
    J Am Pharm Assoc (2003); 2016; 56(4):455-60. PubMed ID: 27245855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication adherence program: adherence challenges and interventions in type 2 diabetes.
    Odegard PS; Carpinito G; Christensen DB
    J Am Pharm Assoc (2003); 2013; 53(3):267-72. PubMed ID: 23699675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: Osteoporosis.
    Goode JV; Swiger K; Bluml BM
    J Am Pharm Assoc (2003); 2004; 44(2):152-60. PubMed ID: 15098849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacist home visits: A 1-year experience from a community pharmacy.
    Monte SV; Passafiume SN; Kufel WD; Comerford P; Trzewieczynski DP; Andrus K; Brody PM
    J Am Pharm Assoc (2003); 2016 Jan; 56(1):67-72. PubMed ID: 26802924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a community pharmacy workflow process to identify and follow up with prescription abandonment.
    Chancy P; Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S129-S135. PubMed ID: 31231004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacists' work activities in the United States during 2000.
    Schommer JC; Pedersen CA; Doucette WR; Gaither CA; Mott DA
    J Am Pharm Assoc (Wash); 2002; 42(3):399-406. PubMed ID: 12030625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.